Patent & IP news for April 14, 2016

Life as an IP Lawyer: Bratislava, Slovakia from ipkitten.blogspot.com

The AmeriKat's professional life, be it on the Kat or sat at her desk litigating her hours away, involves a huge amount of coordination, support and opposition with lawyers from all over the world ...

Share via E–mail | Twitter | Facebook

You Wouldn't Steal a Carouselambra (other Led Zeppelin songs are available) from ipkitten.blogspot.com

But if I could download 
one from the internet...Led Zeppelin are currently facing a jury trial to determine whether 'Stairway to Heaven' infringes copyright in Spirit’s ‘Taurus’. 

The case has been discussed previously ...

Share via E–mail | Twitter | Facebook

BREAKING: Safe passage through Panama - EU Trade Secrets Directive approved, but not without protest from ipkitten.blogspot.com

The AmeriKat enjoys her secrecy, but will the
passing of the EU Trade Secrets Directive
change anything?  Following close on the heels of the US Senate's unanimous approval of the Defend Trade Secrets Act ...

Share via E–mail | Twitter | Facebook

PTAB Denies IPR Petitions against Cold Spring Harbor Laboratory Patents from www.patentdocs.org

By Kevin E. Noonan -- Cold Spring Harbor Laboratory (CSHL) is a storied institution in molecular biology, being the site of annual meetings related to this view of life since Schrodinger proposed to use quantitative methods ...

Share via E–mail | Twitter | Facebook

Analysis: WTO Amendment On Access To Medicines Faces EU Conundrum from www.ip-watch.org

After waiting for over a decade, the World Trade Organization is finally close to achieving the first ever amendment to its rule-book, with only a handful of members still needing to formally accept new intellectual ...

Share via E–mail | Twitter | Facebook

Plaintiff Collaterally Estopped From Establishing Earlier Invention Date from docketreport.blogspot.com

The court granted defendants' motion for summary judgment that plaintiff was collaterally estopped from claiming an earlier invention date for one of its internet security patents. "Defendants rely on [an earlier] order in [one of ...

Share via E–mail | Twitter | Facebook

More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents from www.iposgoode.ca

From Lab Bench to Court Bench: The Science, the Law, and the CRISPR Patent Dispute Whenever a new technology has the potential to be ground-breaking and extremely valuable, there are bound to be disputes about ...

Share via E–mail | Twitter | Facebook

Trade Secrets Directive Clears European Parliament Despite Concerns from www.ip-watch.org

Rejecting calls for a vote to be delayed until the European Commission proposes tougher whistle-blower protections, the European Parliament on 14 April approved by 503-131 new rules giving companies redress for theft or misuse of ...

Share via E–mail | Twitter | Facebook

101 abstract idea vending machine bilski alice from allthingspros.blogspot.com

Takeaway:  A PTAB panel found that the Examiner failed to establish a prima facie case of unpatentability in reversing an Examiner’s § 101 rejection relating to hardware/software technology for establishing credit on an automatic ...

Share via E–mail | Twitter | Facebook

Oracle fundamentally disagrees with Judge Alsup on how to instruct jury on fair use in Google case from www.fosspatents.com

On a recent occasion, Judge Alsup has correctly stated what the Federal Circuit ruled to be copyright-protected in this case (unlike in an order earlier in the build-up to the May retrial). But when I ...

Share via E–mail | Twitter | Facebook

Plagiarism episode ends badly for chemistry grad student at UNLV from ipbiz.blogspot.com

See the ReviewJournal post titled Appeals court rules against ex-UNLV student in plagiarism case.

From the unpublished CA9 opinion [ 2016 U.S. App. LEXIS 6371 ]


Gamage argues that the district court erred in granting summary ...

Share via E–mail | Twitter | Facebook

An Inflectra Update: Janssen Requests an Expedited Trial from www.patentdocs.org

By Andrew Williams -- As we reported last week, the U.S. Food and Drug Administration approved Celltrion's application to market Inflectra, a biosimilar to Janssen Biotech Inc.'s REMICADE (infliximab) anti-TNF-α antibody. On Tuesday ...

Share via E–mail | Twitter | Facebook